The Impact of Doxycycline as an Adjunctive Therapy on Prostate-Specific Antigen, Quality of Life, and Cognitive Function in Metastatic Prostate Cancer Patients: A Phase II Randomized Controlled Trial.
Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
José Guzmán-EsquivelClinical Epidemiology Research Unit, Mexican Institute of Social Security Institute, Villa de Alvarez, Colima 28984, Mexico.ORCID 0000-0002-6727-0051
Hossana S Garcia-GarciaClinical Epidemiology Research Unit, Mexican Institute of Social Security Institute, Villa de Alvarez, Colima 28984, Mexico.
Gustavo A Hernández-FuentesDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0003-4685-3095
Jesús Venegas-RamírezDepartment of Nephrology, Mexican Institute of Social Security (IMSS), General Hospital of Zone No. 1, IMSS, Villa de Alvarez 28984, Mexico.ORCID 0000-0002-9826-1895
Carlos D Barajas-MejíaClinical Epidemiology Research Unit, Mexican Institute of Social Security Institute, Villa de Alvarez, Colima 28984, Mexico.
Idalia Garza-VelozMolecular Medicine Laboratory, Unidad de Medicina Humana y Ciencias de la Salud, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0002-6307-1696
Margarita L Martinez-FierroMolecular Medicine Laboratory, Unidad de Medicina Humana y Ciencias de la Salud, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0003-1478-9068
Nancy E Magaña-VergaraFaculty of Chemical Sciences, University of Colima, Coquimatlan 28400, Mexico.ORCID 0000-0002-7079-0752
José A Guzmán-SolórzanoDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Patricia Calvo-SotoCoordination of Planning and Institutional Liaison, IMSS OOAD Colima, Colima 28030, Mexico.ORCID 0000-0002-8432-0997
Oscar N Avila-ZamoraState Cancerology Institute of Colima, Health Services of the Mexican Social Security Institute for Welfare (IMSS-BIENESTAR), Colima 28085, Mexico.
Mercedes Fuentes-MurguiaDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Gabriel Ceja-EspírituDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Iván Delgado-EncisoDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0001-9848-862X
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Impact of Doxycycline as an Adjunctive Therapy on Prostate-Specific Antigen, Quality of Life, and Cognitive Function in Metastatic Prostate Cancer Patients: A Phase II Randomized Controlled Trial. · full record | OpenQuestion